benzimidazole has been researched along with Leishmaniasis, Cutaneous in 1 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardoso Santos, C | 1 |
| Meuser Batista, M | 1 |
| Inam Ullah, A | 1 |
| Rama Krishna Reddy, T | 1 |
| Soeiro, MNC | 1 |
1 other study available for benzimidazole and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Drug screening using shape-based virtual screening and
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Cells, Cultured; Disease Models, Animal; Drug Evaluat | 2021 |